Dyadem is a provider of quality lifecycle management and risk lifecycle management solutions.
Dyadem said that PHA-Pro delivers process hazard analysis (PHA) capabilities for the process industries. The PHA methodology is an integral part of a pharmaceutical manufacturer’s process safety management program and results in safer and predictable production processes.
Dyadem also said that its PHA-Pro helps manage risk lifecycle management processes, and was built to reflect the risk mitigation initiatives and operating environments of the various process industries. This is essential to optimizing work time, minimizing work stoppages, and reducing the potential for undesirable events, while improving the safety and quality of a given product for consumers.
With PHA-Pro being used across its global organization, Wyeth has integrated the knowledge and expertise of all departments into its PHA studies and provided the Environmental Health and Safety department visibility into the overall business process, making everyone at the company aware of its global business and safety strategy, according to Dyadem.
Kevin North, president and CEO of Dyadem, said: “Pharmaceutical companies have traditionally had challenges ensuring consistency and accuracy in their risk assessments, but with our Risk Lifecycle Management solutions, we have given the industry a chance to address this. Wyeth shows how important it is to standardize risk mitigation initiatives, and provide an avenue for input from all areas of a business.”